Centiva Capital, LP Laboratory Corp Of America Holdings Transaction History

Centiva Capital, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$209.01 - $232.56 $1.77 Million - $1.97 Million	8,464 New	8,464 $1.85 Million
Q4 2022 Feb 14, 2023	BUY	$203.72 - $248.97 $244,871 - $299,261	1,202 Added 97.25%	2,438 $573,000
Q3 2022 Nov 14, 2022	SELL	$204.81 - $262.19 $159,137 - $203,721	-777 Reduced 38.6%	1,236 $253,000
Q2 2022 Aug 15, 2022	SELL	$213.86 - $277.87 $676,653 - $879,180	-3,164 Reduced 61.12%	2,013 $472,000
Q1 2022 May 16, 2022	BUY	$259.82 - $298.18 $1.35 Million - $1.54 Million	5,177 New	5,177 $1.37 Million
Q1 2021 May 17, 2021	SELL	$204.88 - $255.03 $293,797 - $365,713	-1,434 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$186.91 - $214.42 $268,028 - $307,478	1,434 New	1,434 $292,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.